RediNews
ETFs Holding ASMB »    ASMB Historical Stock Prices »
ASMB News Video: Mon, Apr 15, 2019, 1:33 PM — Monday Sector Laggards: Biotechnology, Drugs


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Assembly Biosciences is a clinical stage biotechnology company developing two platform programs: a new class of oral therapeutic candidates for the treatment of hepatitis B virus infection and a class of oral synthetic live biotherapeutic candidates for the treatment of disorders associated with the microbiome. Co.'s Microbiome program consists of a platform that includes disease targeted strain identification and selection process, methods for strain isolation and growth under current Good Manufacturing Practice conditions, and a patent pending delivery system, GEMICEL®, which allows for targeted oral delivery of live biologic and conventional therapies to the lower gastrointestinal tract. Self directed investors in Assembly Biosciences Inc will be interested in keeping up with all Assembly Biosciences Inc news they can find, both ASMB news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on ASMB. At RediNews, we simplify this task by presenting both ASMB news releases originating from Assembly Biosciences Inc itself, and ASMB news from a variety of media outlets. Visitors can browse this news online and through our ASMB RSS news feed.

ASMB News

ASMB News — Articles, Videos, & Press Releases

Notable Monday Option Activity: ARQL, ASMB, ZAYO
Monday, April 15, 2019, 3:22 PM — Stock Options Channel
Assembly Biosciences Becomes Oversold (ASMB)
Monday, April 15, 2019, 12:03 PM — Dividend Channel
Notable Friday Option Activity: ALGN, SKX, ASMB
Friday, April 5, 2019, 3:16 PM — Stock Options Channel
First Week of November 15th Options Trading For Assembly Biosciences
Friday, March 22, 2019, 10:42 AM — Stock Options Channel
Noteworthy Thursday Option Activity: ASMB, BHVN, ADNT
Thursday, March 14, 2019, 3:25 PM — Stock Options Channel
Analysts Anticipate IHE Will Reach $200
Thursday, February 21, 2019, 9:30 AM — ETF Channel
Generic-Drugs Outlook: Price Erosion to Hurt Near-Term Prospects
Tuesday, February 19, 2019, 4:47 PM — Zacks
Short Interest In Assembly Biosciences Makes 42% Move
Tuesday, February 12, 2019, 6:09 PM — Market News Video
Mylan (MYL) Jumps: Stock Rises 7.1%
Thursday, January 31, 2019, 8:30 AM — Zacks
Surprising Analyst 12-Month Target For XPH
Monday, January 21, 2019, 8:39 AM — ETF Channel
Commit To Purchase Assembly Biosciences At $22.50, Earn 28.8% Annualized Using Options
Thursday, January 3, 2019, 11:34 AM — Stock Options Channel
Analysts Anticipate XPH To Hit $58
Tuesday, December 18, 2018, 7:56 AM — ETF Channel
How The Parts Add Up: XPH Headed For $58
Thursday, November 15, 2018, 7:22 AM — ETF Channel
How The Parts Add Up: PBSM Targets $33
Monday, October 15, 2018, 7:44 AM — ETF Channel
First Week of May 2019 Options Trading For Assembly Biosciences (ASMB)
Friday, October 5, 2018, 10:34 AM — Stock Options Channel
Assembly Biosciences Enters Oversold Territory (ASMB)
Thursday, October 4, 2018, 5:20 PM — Dividend Channel
Noteworthy Thursday Option Activity: ASMB, BKS, ITG
Thursday, October 4, 2018, 3:31 PM — Stock Options Channel
Commit To Buy Assembly Biosciences At $30, Earn 41.4% Annualized Using Options
Tuesday, September 18, 2018, 11:44 AM — Stock Options Channel
Add Up The Parts: XPH Could Be Worth $58
Thursday, September 13, 2018, 8:22 AM — ETF Channel
Investors Grab ASMB Even Cheaper Than Its Secondary Stock Offering
Wednesday, August 15, 2018, 11:18 AM — Dividend Channel
The Math Shows XPH Can Go To $56
Friday, August 3, 2018, 8:49 AM — ETF Channel
Land This Bargain Even Cheaper Than CEO and President Small Did
Tuesday, July 24, 2018, 3:11 PM — Dividend Channel
Look Under The Hood: XPH Has 25% Upside
Tuesday, July 3, 2018, 8:08 AM — ETF Channel
ASMB Crosses Below Key Moving Average Level
Monday, June 25, 2018, 1:57 PM — Market News Video
Commit To Buy Assembly Biosciences At $35, Earn 28.5% Annualized Using Options
Tuesday, June 19, 2018, 11:58 AM — Stock Options Channel
Assembly Biosciences (ASMB) Shares Cross Below 200 DMA
Wednesday, May 30, 2018, 5:56 PM — Market News Video
How The Parts Add Up: PBE Targets $63
Thursday, May 24, 2018, 8:12 AM — ETF Channel
ASMB Makes Notable Cross Below Critical Moving Average
Tuesday, May 8, 2018, 11:58 AM — Market News Video
ASMB is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

PRTK News
KTWO News
EYES News
NVTA News
BXLT News
PRTO News
LDRH News
NVRO News
COLL News
ATRA News

RediNews invites those seeking web page financial content for any internet portal, especially any vertical portal specializing in the markets where there is a web page for business, web page for markets, web page finance, etc., to integrate our free web site content, our RSS news feeds. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic financial content is ideal for sites that already feature stock data content such as historical stock price information whether in the form of a historical stock price table or a web page chart image, to supplement the other custom stock market content displayed.

ASMB News | www.RediNews.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.